199 related articles for article (PubMed ID: 32801296)
1. Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centre.
Huang H; Xu C; Gao J; Li B; Qin T; Xu Z; Ren S; Zhang Y; Jiao M; Qu S; Pan L; Hu N; Liu J; Cai W; Zhang Y; Wu D; Zhang P; Gale RP; Huang G; Zhou J; Shi L; Xiao Z
Blood Cancer J; 2020 Aug; 10(8):83. PubMed ID: 32801296
[TBL] [Abstract][Full Text] [Related]
2. Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD.
Claessens YE; Park S; Dubart-Kupperschmitt A; Mariot V; Garrido C; Chrétien S; Dreyfus F; Lacombe C; Mayeux P; Fontenay M
Blood; 2005 May; 105(10):4035-42. PubMed ID: 15677568
[TBL] [Abstract][Full Text] [Related]
3. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
Claessens YE; Bouscary D; Dupont JM; Picard F; Melle J; Gisselbrecht S; Lacombe C; Dreyfus F; Mayeux P; Fontenay-Roupie M
Blood; 2002 Mar; 99(5):1594-601. PubMed ID: 11861273
[TBL] [Abstract][Full Text] [Related]
4. Serum erythropoietin and erythropoiesis in patients with myelodysplastic syndromes.
Bowen DT; Jacobs A; Cotes PM; Lewis TC
Eur J Haematol; 1990 Jan; 44(1):30-2. PubMed ID: 2307217
[TBL] [Abstract][Full Text] [Related]
5. Dyserythropoiesis of myelodysplastic syndromes.
Lefèvre C; Bondu S; Le Goff S; Kosmider O; Fontenay M
Curr Opin Hematol; 2017 May; 24(3):191-197. PubMed ID: 28072603
[TBL] [Abstract][Full Text] [Related]
6. Erythroid nuclear dysplasia is associated with inferior outcomes for patients with myelodysplastic syndrome undergoing allogeneic hematopoietic cell transplantation.
Chen EC; Li S; Yang J; Zhang ML; Hasserjian R; Chen YB; Brunner AM; DeFilipp Z
Leuk Res; 2021 Oct; 109():106625. PubMed ID: 34062365
[TBL] [Abstract][Full Text] [Related]
7. Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.
Bacher U; Haferlach C; Alpermann T; Kern W; Schnittger S; Haferlach T
Haematologica; 2011 Sep; 96(9):1284-92. PubMed ID: 21606170
[TBL] [Abstract][Full Text] [Related]
8. Analysis of erythroid maturation in the nonlysed bone marrow with help of radar plots facilitates detection of flow cytometric aberrations in myelodysplastic syndromes.
Violidaki D; Axler O; Jafari K; Bild F; Nilsson L; Mazur J; Ehinger M; Porwit A
Cytometry B Clin Cytom; 2020 Sep; 98(5):399-411. PubMed ID: 32543774
[TBL] [Abstract][Full Text] [Related]
9. Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience.
Alzahrani M; Power M; Abou Mourad Y; Barnett M; Broady R; Forrest D; Gerrie A; Hogge D; Nantel S; Sanford D; Song K; Sutherland H; Toze C; Nevill T; Narayanan S
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1209-1215. PubMed ID: 29474870
[TBL] [Abstract][Full Text] [Related]
10. Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes.
Neukirchen-Strapatsas J; Tuechler H; Porta MD; Fenaux P; Guerci A; Haas R; Rossi M; Sapena R; Sperr WR; Strupp C; Stamatoullas A; Valent P; Germing U; Bennett JM
Leuk Res; 2019 Feb; 77():8-13. PubMed ID: 30605856
[TBL] [Abstract][Full Text] [Related]
11. Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome.
Narukawa K; Masuda A; Takahashi T
Int J Hematol; 2021 Jun; 113(6):775-776. PubMed ID: 33864622
[No Abstract] [Full Text] [Related]
12. Role of Plasma Gelsolin Protein in the Final Stage of Erythropoiesis and in Correction of Erythroid Dysplasia In Vitro.
Han SY; Lee EM; Kim S; Kwon AM; Baek EJ
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992584
[TBL] [Abstract][Full Text] [Related]
13. Expressional changes of genes and miRNA in common megakaryocyte-erythroid progenitors from lower-risk myelodysplastic syndrome.
Maki K; Sasaki K; Nagata Y; Nagasawa F; Nakamura Y; Ogawa S; Mitani K
Int J Hematol; 2014 Oct; 100(4):361-9. PubMed ID: 25056847
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis in a cohort of 102 patients with myelodysplastic syndrome characterized by erythroid hyperplasia].
Yu Y; Sun AN; Chen SN; Wang QR; Zhang TT; Wu DP
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):29-33. PubMed ID: 28056320
[No Abstract] [Full Text] [Related]
15. Prognostic Significance of Platelet Recovery in Myelodysplastic Syndromes With Severe Thrombocytopenia.
Tang Y; Zhang X; Han S; Chu T; Qi J; Wang H; Tang X; Qiu H; Fu C; Ruan C; Wu D; Han Y
Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):217S-222S. PubMed ID: 30296835
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes.
Merchav S; Nielsen OJ; Rosenbaum H; Sharon R; Brenner B; Tatarsky I; Scigalla P; Wieczorek L
Leukemia; 1990 Nov; 4(11):771-4. PubMed ID: 2232891
[TBL] [Abstract][Full Text] [Related]
17. What is ineffective erythropoiesis in myelodysplastic syndromes?
Bowen D
Leuk Lymphoma; 1995 Jul; 18(3-4):243-7. PubMed ID: 8535189
[TBL] [Abstract][Full Text] [Related]
18. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
19. Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand.
Backx B; Broeders L; Hoefsloot LH; Wognum B; Löwenberg B
Leukemia; 1996 Mar; 10(3):466-72. PubMed ID: 8642863
[TBL] [Abstract][Full Text] [Related]
20. Proposal of criteria for dyserythropoiesis in the diagnosis of myelodysplastic syndromes.
Kawai N; Matsuda A; Jinnai I; Ichimura T; Kayano H; Okamura D; Ishikawa M; Maeda T; Hata T; Miyazaki Y; Asou N; Bessho M; Tomonaga M
Int J Hematol; 2016 Feb; 103(2):227-33. PubMed ID: 26608365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
